This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 299086 Submitted by lobbyist on: March 6, 2013 01:03:10 PM Accepted by Registrar on: March 8, 2013 03:27:32 PM
Designated Filer Information
Stuart Chatterley, Jo-Ann
15169 Royal Avenue
White Rock, BC, V4B 1M2
604-541-9553
Canada
Organization Information
Janssen Inc.
Pharmaceutical company. Sales, marketing and promotion of prescription pharmaceuticals in women's health, mental health, pain, oncology, HIV, and Immunology
19 Green Belt Drive
Toronto, ON, M3C 1L9
416-382-5000
Canada
Relevant Affiliates
Type:
Business Name
Mailing Address
Contact Information
Johnson and Johnson
Canadian Information centre Johnson and Johnson Inc 199 Grandview Road
Skillman,
NJ
08558
United States of America
Phone:
416-382-5000
Government or Government Agency Funding
The organization does not receive any funding from a government or government agency.
Other Controlling or Directing Interests
The organization has no other controlling or directing interests.
Active Registration Period
March 6, 2013
October 2, 2013
Organization's In-House Lobbyists
Name:
Badger, Derek
March 6, 2013
Inactivation Date:
October 3, 2013
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Janssen Ince is a biopharmacuetical company that is part of the J&J family of companies. We have proven research and deliver therapies in some of the world's most complex and serious diseases including: Virology, Immunology, Oncology, Diabetes, Women's Health, Neuroscience, and Pain. Our lobby purpose is to update on JI's research pipeline, review current standards of practice in BC with respect to JI's areas of research, and identify treatment gaps, and focus on ways through partnerships to improve the health outcomes for British Columbians. Discuss reimbursement of JI's innovative biotech medicines in British Columbia.
Target Contacts
Target Type
Name
Title or Constituency
Date Added
MLA
de Jong,
Mike
Abbotsford West
March 6, 2013
MLA
Dix,
Adrian
Vancouver-Kingsway
March 6, 2013
MLA
Farnworth,
Mike
Port Coquitlam
March 6, 2013
MLA
Hogg,
Gordon
Surrey-White Rock
March 6, 2013
MLA
Horgan,
John
Juan de Fuca
March 6, 2013
MLA
Krog,
Leonard
Nanaimo
March 6, 2013
MLA
Kwan,
Jenny
Vancouver-Mount Pleasant
March 6, 2013
MLA
MacDiarmid,
Margaret
Vancouver-Fairview
March 6, 2013
MLA
Ralston,
Bruce
Surrey-Whalley
March 6, 2013
MLA
Simpson,
Shane
Vancouver-Hastings
March 6, 2013
Name:
Brown, Julia
March 6, 2013
Inactivation Date:
October 3, 2013
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Janssen Ince is a biopharmacuetical company that is part of the J&J family of companies. We have proven research and deliver therapies in some of the world's most complex and serious diseases including: Virology, Immunology, Oncology, Diabetes, Women's Health, Neuroscience, and Pain. Our lobby purpose is to update on JI's research pipeline, review current standards of practice in BC with respect to JI's areas of research, and identify treatment gaps, and focus on ways through partnerships to improve the health outcomes for British Columbians. Discuss reimbursement of JI's innovative biotech medicines in British Columbia.
Target Contacts
Target Type
Name
Title or Constituency
Date Added
MLA
de Jong,
Mike
Abbotsford West
March 6, 2013
MLA
Dix,
Adrian
Vancouver-Kingsway
March 6, 2013
MLA
Farnworth,
Mike
Port Coquitlam
March 6, 2013
MLA
Hogg,
Gordon
Surrey-White Rock
March 6, 2013
MLA
Horgan,
John
Juan de Fuca
March 6, 2013
MLA
Krog,
Leonard
Nanaimo
March 6, 2013
MLA
Kwan,
Jenny
Vancouver-Mount Pleasant
March 6, 2013
MLA
MacDiarmid,
Margaret
Vancouver-Fairview
March 6, 2013
MLA
Ralston,
Bruce
Surrey-Whalley
March 6, 2013
MLA
Simpson,
Shane
Vancouver-Hastings
March 6, 2013
Name:
Debolt, Michael
March 6, 2013
Inactivation Date:
October 3, 2013
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Janssen Ince is a biopharmacuetical company that is part of the J&J family of companies. We have proven research and deliver therapies in some of the world's most complex and serious diseases including: Virology, Immunology, Oncology, Diabetes, Women's Health, Neuroscience, and Pain. Our lobby purpose is to update on JI's research pipeline, review current standards of practice in BC with respect to JI's areas of research, and identify treatment gaps, and focus on ways through partnerships to improve the health outcomes for British Columbians. Discuss reimbursement of JI's innovative biotech medicines in British Columbia.
Target Contacts
Target Type
Name
Title or Constituency
Date Added
MLA
de Jong,
Mike
Abbotsford West
March 6, 2013
MLA
Dix,
Adrian
Vancouver-Kingsway
March 6, 2013
MLA
Farnworth,
Mike
Port Coquitlam
March 6, 2013
MLA
Hogg,
Gordon
Surrey-White Rock
March 6, 2013
MLA
Horgan,
John
Juan de Fuca
March 6, 2013
MLA
Krog,
Leonard
Nanaimo
March 6, 2013
MLA
Kwan,
Jenny
Vancouver-Mount Pleasant
March 6, 2013
MLA
MacDiarmid,
Margaret
Vancouver-Fairview
March 6, 2013
MLA
Ralston,
Bruce
Surrey-Whalley
March 6, 2013
MLA
Simpson,
Shane
Vancouver-Hastings
March 6, 2013
Name:
Fraser, Graeme
March 6, 2013
Inactivation Date:
October 3, 2013
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Janssen Ince is a biopharmacuetical company that is part of the J&J family of companies. We have proven research and deliver therapies in some of the world's most complex and serious diseases including: Virology, Immunology, Oncology, Diabetes, Women's Health, Neuroscience, and Pain. Our lobby purpose is to update on JI's research pipeline, review current standards of practice in BC with respect to JI's areas of research, and identify treatment gaps, and focus on ways through partnerships to improve the health outcomes for British Columbians. Discuss reimbursement of JI's innovative biotech medicines in British Columbia.
Target Contacts
Target Type
Name
Title or Constituency
Date Added
MLA
de Jong,
Mike
Abbotsford West
March 6, 2013
MLA
Dix,
Adrian
Vancouver-Kingsway
March 6, 2013
MLA
Farnworth,
Mike
Port Coquitlam
March 6, 2013
MLA
Hogg,
Gordon
Surrey-White Rock
March 6, 2013
MLA
Horgan,
John
Juan de Fuca
March 6, 2013
MLA
Krog,
Leonard
Nanaimo
March 6, 2013
MLA
Kwan,
Jenny
Vancouver-Mount Pleasant
March 6, 2013
MLA
MacDiarmid,
Margaret
Vancouver-Fairview
March 6, 2013
MLA
Ralston,
Bruce
Surrey-Whalley
March 6, 2013
MLA
Simpson,
Shane
Vancouver-Hastings
March 6, 2013
Name:
Korte, Brent
March 6, 2013
Inactivation Date:
October 3, 2013
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Janssen Ince is a biopharmacuetical company that is part of the J&J family of companies. We have proven research and deliver therapies in some of the world's most complex and serious diseases including: Virology, Immunology, Oncology, Diabetes, Women's Health, Neuroscience, and Pain. Our lobby purpose is to update on JI's research pipeline, review current standards of practice in BC with respect to JI's areas of research, and identify treatment gaps, and focus on ways through partnerships to improve the health outcomes for British Columbians. Discuss reimbursement of JI's innovative biotech medicines in British Columbia.
Target Contacts
Target Type
Name
Title or Constituency
Date Added
MLA
de Jong,
Mike
Abbotsford West
March 6, 2013
MLA
Dix,
Adrian
Vancouver-Kingsway
March 6, 2013
MLA
Farnworth,
Mike
Port Coquitlam
March 6, 2013
MLA
Hogg,
Gordon
Surrey-White Rock
March 6, 2013
MLA
Horgan,
John
Juan de Fuca
March 6, 2013
MLA
Krog,
Leonard
Nanaimo
March 6, 2013
MLA
Kwan,
Jenny
Vancouver-Mount Pleasant
March 6, 2013
MLA
MacDiarmid,
Margaret
Vancouver-Fairview
March 6, 2013
MLA
Ralston,
Bruce
Surrey-Whalley
March 6, 2013
MLA
Simpson,
Shane
Vancouver-Hastings
March 6, 2013
Name:
Stuart Chatterley, Jo-Ann
March 6, 2013
Inactivation Date:
October 3, 2013
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Janssen Ince is a biopharmacuetical company that is part of the J&J family of companies. We have proven research and deliver therapies in some of the world's most complex and serious diseases including: Virology, Immunology, Oncology, Diabetes, Women's Health, Neuroscience, and Pain. Our lobby purpose is to update on JI's research pipeline, review current standards of practice in BC with respect to JI's areas of research, and identify treatment gaps, and focus on ways through partnerships to improve the health outcomes for British Columbians. Discuss reimbursement of JI's innovative biotech medicines in British Columbia.
